Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06960317 · ClinicalTrials.gov registry record · NA
Empathy Through Pain Control: Lidocaine Paracervical Block for IUD Placements
A NA study of Contraception and Pain, Acute, sponsored by University of California, San Diego.
- Recruiting
- Registry status
- NA
- Development phase
- 204
- Enrollment target
- 1
- Study location
NCT06960317: Recruiting NA study of Contraception and Pain, Acute, sponsored by University of California, San Diego.
NCT06960317 is a NA study of Contraception and Pain, Acute that is actively recruiting participants, run by University of California, San Diego. The registered enrollment target is 204 participants, below the 452-participant average among 72 other Contraception trials with a reported enrollment target (55% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06960317, a NA study of Contraception and Pain, Acute, is actively recruiting participants, sponsored by University of California, San Diego.
- RECRUITING
- Registry status
- NA
- Development phase
- 204 participants
- Enrollment target
- 1
- Study location
Study Summary
The goal of this research study is to learn more about how different uses of a numbing medication might affect pain levels while getting an IUD placed. The investigators are also studying participants opinions of their clinicians' empathy. The investigators are inviting patients who arrive at their clinic visit seeking an IUD. Usually, at University of California, San Diego (UCSD), for patients who have never delivered a baby, clinicians use a buffered paracervical block for before IUD placement. The purpose of this research study is to investigate whether a "buffered" (2 cc of sodium bicarbonate, 18 cc of 1% lidocaine) paracervical block (numbing medication given on both sides of the cervix) is effective in reducing pain during IUD placement in individuals with prior C-sections, the difference between buffered and unbuffered for nulliparous patients, and whether a medicated gel reduces pain with the paracervical block.
Primary Outcome
Does buffered 1% lidocaine paracervical block decrease pain during IUD. placement procedures. Pain will be measured on a 10-cm Visual Analog Scale (VAS) with score points ranging from 0-10, where 0 means "No pain" and 10 means "Worst pain possible."
Conditions Studied
Interventions
- OTHER Sham Comparator
- DRUG Buffered Lidocaine
- DRUG Unbuffered lidocaine
- DRUG Xylocaine jelly 2%
- DRUG Surgilube
Study Locations (1)
California
- University of California, San Diego - La Jolla
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 204 participants |
| Start Date | 2025-06-04 |
| Est. Completion | 2028-06-30 |
| Phase | NA |
What NCT06960317 shows while recruiting
NCT06960317 is an interventional study that assigns participants to a tested intervention. The registered 204 participants enrollment target is mid-sized for trials with a published cap, below the 452-participant average among 72 other Contraception trials with a reported enrollment target (55% lower).
The record links to 3 conditions, with Contraception appearing as the primary indexed condition, and to 5 interventions - of which Sham Comparator is the first listed.
NCT06960317 reports a single indexed study location in California.
Frequently Asked Questions
What is clinical trial NCT06960317 about?
NCT06960317 is a clinical study titled "Empathy Through Pain Control: Lidocaine Paracervical Block for IUD Placements". The goal of this research study is to learn more about how different uses of a numbing medication might affect pain levels while getting an IUD placed. The investigators are also studying participants opinions of their clinicians' empathy. The investigators are inviting patients who arrive at their...
What is the current status of trial NCT06960317?
This trial is currently recruiting. It is a NA study. The enrollment target is 204 participants. The study started on 2025-06-04. Estimated completion is 2028-06-30.
What conditions does trial NCT06960317 study?
This clinical trial studies the following conditions: Contraception, Pain, Acute, Anesthesia, Local.
What interventions are being tested in trial NCT06960317?
The interventions under investigation include: Sham Comparator (OTHER), Buffered Lidocaine (DRUG), Unbuffered lidocaine (DRUG), Xylocaine jelly 2% (DRUG), Surgilube (DRUG).
Who is sponsoring clinical trial NCT06960317?
This trial is sponsored by University of California, San Diego, which has 775 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06960317 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Contraception
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06960317's enrollment target sits among peer trials
204 33rd of 72 higher than 40 of 72 other Contraception trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Contraception trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Patient-clinical Linkages to Improve Trust and Engagement in Postpartum Healthcare
RECRUITING · NA
-
Hormonal Contraception Access Through Pharmacist Prescribing Implementation
RECRUITING · NA
-
Prospective Multi-Center Trial for FemBloc Permanent Birth Control
RECRUITING · NA
-
Contraceptive Efficacy Study of Ovaprene
RECRUITING · NA
-
Intervening on Women's Health for Rural Young Cancer Survivors
RECRUITING · NA
-
Patient-centered Information on Permanent Contraception
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03481010 · 204 participants · NA
Periacetabular Osteotomy With and Without Arthroscopic Management of Central Compartment Pathology
- NCT04249830 · 204 participants · NA
Stem Cell Transplant From Donors After Alpha Beta Cell Depletion in Children and Young Adults
- NCT04503395 · 204 participants · NA
ShOrt neCK AAA RAndomized Trial - ESAR and FEVAR: SOCRATES
- NCT04793776 · 204 participants · NA
Manage Emotions to Reduce Aggression (MERA)
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI